Endo Wants Out Of Investors' Stock Inflation Suit
Endo International PLC sought to squash investors' claims it had artificially inflated its stock prices by hiking its generic drug prices in tandem with competitors, telling a Pennsylvania federal judge that...To view the full article, register now.
Already a subscriber? Click here to view full article